Receptos Reports Positive Results for the Maintenance Period of the Phase 2 TOUCHSTONE Trial of Ozanimod in Ulcerative Colitis
April 16, 2015 at 08:01 AM EDT
Receptos, Inc. (Nasdaq: RCPT) today announced that the maintenance period of TOUCHSTONE, the Phase 2 trial of ozanimod (formerly ...